151 related articles for article (PubMed ID: 11149409)
1. Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.
Garcia-Lora A; Algarra I; Gaforio JJ; Ruiz-Cabello F; Garrido F
Int J Cancer; 2001 Jan; 91(1):109-19. PubMed ID: 11149409
[TBL] [Abstract][Full Text] [Related]
2. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
[TBL] [Abstract][Full Text] [Related]
3. Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.
Shiloni E; Karp SE; Custer MC; Shilyansky J; Restifo NP; Rosenberg SA; Mulé JJ
Cancer Immunol Immunother; 1993 Oct; 37(5):286-92. PubMed ID: 8402732
[TBL] [Abstract][Full Text] [Related]
4. Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.
Pedrinaci S; Algarra I; Garcia Lora A; Gaforio JJ; Perez M; Garrido F
Int J Clin Lab Res; 1999; 29(4):166-73. PubMed ID: 10784379
[TBL] [Abstract][Full Text] [Related]
5. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
Pérez M; Algarra I; Ljunggren HG; Caballero A; Mialdea MJ; Gaforio JJ; Klein G; Kärre K; Garrido F
Int J Cancer; 1990 Aug; 46(2):258-61. PubMed ID: 2116997
[TBL] [Abstract][Full Text] [Related]
6. Differential mRNA levels of c-myc, c-fos and MHC class I in several clones of a murine fibrosarcoma.
Gaforio JJ; Pérez M; Algarra I; Mialdea MJ; Ljunggren HG; Garrido F
Int J Cancer; 1991 Dec; 49(6):906-10. PubMed ID: 1959995
[TBL] [Abstract][Full Text] [Related]
7. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
8. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
[TBL] [Abstract][Full Text] [Related]
9. NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma.
Algarra I; Ohlén C; Perez M; Ljunggren HG; Klein G; Garrido F; Kärre K
Int J Cancer; 1989 Oct; 44(4):675-80. PubMed ID: 2507453
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F
Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185
[TBL] [Abstract][Full Text] [Related]
11. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
Cheng WF; Hung CF; Lin KY; Ling M; Juang J; He L; Lin CT; Wu TC
Gene Ther; 2003 Aug; 10(16):1311-20. PubMed ID: 12883527
[TBL] [Abstract][Full Text] [Related]
13. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Algarra I; Collado A; Garrido F
J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
[TBL] [Abstract][Full Text] [Related]
14. Effects of the major histocompatibility complex loci and T-cell receptor beta-chain repertoire on Theiler's virus-induced demyelinating disease.
Kim BS; Mohindru M; Kang B; Kang HS; Palma JP
J Neurosci Res; 2005 Sep; 81(6):846-56. PubMed ID: 16049971
[TBL] [Abstract][Full Text] [Related]
15. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
Grangeon C; Cormary C; Douin-Echinard V; Favre G; Couderc B; Tilkin-Mariamé AF
Cancer Gene Ther; 2002 Mar; 9(3):282-8. PubMed ID: 11896445
[TBL] [Abstract][Full Text] [Related]
16. Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.
Nanni P; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Rossi I; Cavallo F; Giovarelli M; Forni G; Lollini PL
Br J Cancer; 1996 Nov; 74(10):1564-9. PubMed ID: 8932336
[TBL] [Abstract][Full Text] [Related]
17. NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells.
Rager-Zisman B; Gopas J; Bar-Eli M; Har-Vardi I; Hammerling GJ; Segal S
Adv Exp Med Biol; 1988; 233():151-60. PubMed ID: 3066149
[TBL] [Abstract][Full Text] [Related]
18. Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
Mialdea MJ; Martin J; Gaforio JJ; Algarra I; Pérez M; Gonzalez A; Ljunggren HG; Garrido F
Int J Cancer; 1992 Aug; 52(1):153-8. PubMed ID: 1500219
[TBL] [Abstract][Full Text] [Related]
19. Local T cell responses induce widespread MHC expression. Evidence that IFN-gamma induces its own expression in remote sites.
Halloran PF; Autenried P; Ramassar V; Urmson J; Cockfield S
J Immunol; 1992 Jun; 148(12):3837-46. PubMed ID: 1602132
[TBL] [Abstract][Full Text] [Related]
20. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
Callahan GN
J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
